[
  {
    "ts": null,
    "headline": "Trump's big beautiful bill: What the pharma industry is watching",
    "summary": "Pharmaceutical stocks, including Pfizer (PFE), Johnson & Johnson (JNJ), Abbvie (ABBV), Novo Nordisk (NVO), and Astrazeneca (AZN), are falling after President Trump said tariffs on the industry are coming \"very soon.\" Chris Meekins, managing director and Washington health policy research analyst at Raymond James, joins Market Domination to discuss potential tariffs and explain how President Trump's tax bill could affect the pharmaceutical industry. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=6248ba62415c0d98cf70db9a6829706b01cfd3a870c8f72a7fa03c8efc5898e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750194995,
      "headline": "Trump's big beautiful bill: What the pharma industry is watching",
      "id": 135340446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks, including Pfizer (PFE), Johnson & Johnson (JNJ), Abbvie (ABBV), Novo Nordisk (NVO), and Astrazeneca (AZN), are falling after President Trump said tariffs on the industry are coming \"very soon.\" Chris Meekins, managing director and Washington health policy research analyst at Raymond James, joins Market Domination to discuss potential tariffs and explain how President Trump's tax bill could affect the pharmaceutical industry. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=6248ba62415c0d98cf70db9a6829706b01cfd3a870c8f72a7fa03c8efc5898e5"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions",
    "summary": "Johnson & Johnson’s first quarter results reflected a steady performance, with the company surpassing Wall Street’s revenue and adjusted profit expectations. Management credited the diversified portfolio across innovative medicine and MedTech as key to navigating industry challenges, particularly the loss of market exclusivity for STELARA, a major pharmaceutical product. CEO Joaquin Duato highlighted, “No other healthcare company has delivered growth through the first year of Lucin exclusivity f",
    "url": "https://finnhub.io/api/news?id=1259bd734cd0f2c1289d892b9aaf602725acf895a28391df6c079d52af167562",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750176680,
      "headline": "Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions",
      "id": 135340761,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson’s first quarter results reflected a steady performance, with the company surpassing Wall Street’s revenue and adjusted profit expectations. Management credited the diversified portfolio across innovative medicine and MedTech as key to navigating industry challenges, particularly the loss of market exclusivity for STELARA, a major pharmaceutical product. CEO Joaquin Duato highlighted, “No other healthcare company has delivered growth through the first year of Lucin exclusivity f",
      "url": "https://finnhub.io/api/news?id=1259bd734cd0f2c1289d892b9aaf602725acf895a28391df6c079d52af167562"
    }
  },
  {
    "ts": null,
    "headline": "Dow falls nearly 300 points on losses for shares of Nike, Merck",
    "summary": "Dow falls nearly 300 points on losses for shares of Nike, Merck",
    "url": "https://finnhub.io/api/news?id=fa3ad9d6238b46bd299edd61aaa5acf776bede5a8259c409cf01d1d7e54d2465",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750169280,
      "headline": "Dow falls nearly 300 points on losses for shares of Nike, Merck",
      "id": 135354667,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Dow falls nearly 300 points on losses for shares of Nike, Merck",
      "url": "https://finnhub.io/api/news?id=fa3ad9d6238b46bd299edd61aaa5acf776bede5a8259c409cf01d1d7e54d2465"
    }
  },
  {
    "ts": null,
    "headline": "ISRG's Minimally Invasive Ecosystem Powers Surgical Precision",
    "summary": "ISRG's robotic platforms, led by da Vinci and Ion, are transforming surgical precision and driving strong stock gains.",
    "url": "https://finnhub.io/api/news?id=d142a308554a2d749ef5fa1ff3b2cec3790bfefc6bca6f3519b7570125d53952",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750167420,
      "headline": "ISRG's Minimally Invasive Ecosystem Powers Surgical Precision",
      "id": 135328607,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "ISRG's robotic platforms, led by da Vinci and Ion, are transforming surgical precision and driving strong stock gains.",
      "url": "https://finnhub.io/api/news?id=d142a308554a2d749ef5fa1ff3b2cec3790bfefc6bca6f3519b7570125d53952"
    }
  },
  {
    "ts": null,
    "headline": "Dow's nearly 150-point drop led by losses for Nike, Merck shares",
    "summary": "Dow's nearly 150-point drop led by losses for Nike, Merck shares",
    "url": "https://finnhub.io/api/news?id=3ddb146542dde5948152bcdfeacebe21ea8abd6821b7e5785f2e93830eeb1bce",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750165620,
      "headline": "Dow's nearly 150-point drop led by losses for Nike, Merck shares",
      "id": 135335191,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Dow's nearly 150-point drop led by losses for Nike, Merck shares",
      "url": "https://finnhub.io/api/news?id=3ddb146542dde5948152bcdfeacebe21ea8abd6821b7e5785f2e93830eeb1bce"
    }
  },
  {
    "ts": null,
    "headline": "I'm Buying Dividend Aristocrats At Bargain Basement Prices",
    "summary": "Read about which two Dividend Aristocrats I'm buying now. They are attractively valued while supporting well-covered dividends.",
    "url": "https://finnhub.io/api/news?id=90be7e976b60b116ef83a265b3fc9ffba2793cc6151b2d5d68e3ba232756f5a3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750147200,
      "headline": "I'm Buying Dividend Aristocrats At Bargain Basement Prices",
      "id": 135325925,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1311163133/image_1311163133.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Read about which two Dividend Aristocrats I'm buying now. They are attractively valued while supporting well-covered dividends.",
      "url": "https://finnhub.io/api/news?id=90be7e976b60b116ef83a265b3fc9ffba2793cc6151b2d5d68e3ba232756f5a3"
    }
  },
  {
    "ts": null,
    "headline": "J&J: launches TECNIS Odyssey intraocular lens",
    "summary": "Johnson & Johnson announces the launch of its new presbyopia-correcting intraocular lens, TECNIS Odyssey IOL, in Europe, the Middle East and Canada. This latest-generation lens offers clear vision...",
    "url": "https://finnhub.io/api/news?id=205dfcef8537d0325c3ec44b950fe4e8d88aef765e30f2f97eeaa5f5ec74b44a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750144573,
      "headline": "J&J: launches TECNIS Odyssey intraocular lens",
      "id": 135325541,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson announces the launch of its new presbyopia-correcting intraocular lens, TECNIS Odyssey IOL, in Europe, the Middle East and Canada. This latest-generation lens offers clear vision...",
      "url": "https://finnhub.io/api/news?id=205dfcef8537d0325c3ec44b950fe4e8d88aef765e30f2f97eeaa5f5ec74b44a"
    }
  }
]